Preclinical Assessment of Efficacy and Safety Analysis of CAR-T Cells (ISIKOK-19) Targeting CD19-Expressing B-Cells for the First Turkish Academic Clinical Trial with Relapsed/Refractory ALL and NHL Patients

OBJECTIVE: Relapsed and refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL) are the focus of studies on hematological cancers. Treatment of these malignancies has undergone recent transformation with the development of new gene therapy and molecular biol...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Turk J Haematol
Main Authors: Taştan, Cihan, Kançağı, Derya Dilek, Turan, Raife Dilek, Yurtsever, Bulut, Çakırsoy, Didem, Abanuz, Selen, Yılancı, Muhammet, Seyis, Utku, Özer, Samed, Mert, Selin, Kayhan, Cavit Kerem, Tokat, Fatma, Açıkel Elmas, Merve, Birdoğan, Selçuk, Arbak, Serap, Yalçın, Koray, Sezgin, Aslıhan, Kızılkılıç, Ebru, Hemşinlioğlu, Cansu, İnce, Ümit, Ratip, Siret, Ovalı, Ercüment
Formato: Artigo
Idioma:Inglês
Publicado em: Galenos Publishing 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7702660/
https://ncbi.nlm.nih.gov/pubmed/32755128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/tjh.galenos.2020.2020.0070
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados